In 1973 a mental health practitioner would have to read 3 research papers per day to stay up to date on the latest high quality research. By 2013 that number rose to 249 papers per day.
André Tomlin, The Mental Elf
What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
After the National Lung Screening Trial (NLST) demonstrated improved lung cancer mortality almost a decade ago, hopes have been raised that low-dose computed tomography could be used to detect lung cancer in asymptomatic populations and improve outcomes by reducing the number of people diagnosed with advanced disease. The publication of the long-awaited Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON) trial last year has provided further evidence of a lung cancer mortality benefit and has provoked further calls to implement national population-based screening programmes, but the case for lung cancer screening remains controversial.
Back to search